RAPT Therapeutics, Inc. Common Stock
Symbol: RAPT (NASDAQ)
35.15
▲ (4.39%) 1.479
Company Description:
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
Key Stats
- Today's Open: $34.263
- Today's High: $35.149
- Today's Low: $33.28
- Today's Volume: 244
- Yesterday Close: $33.67
- Yesterday High: $42.3918
- Yesterday Low: $25.5001
- Yesterday Volume: 3.97M
- Last Min Volume: 0
- Last Min High: $35.149
- Last Min Low: $35.122
- Last Min VWAP: $0
Company Profile
- Name: RAPT Therapeutics, Inc. Common Stock
- Website: https://www.rapt.com
- Listed Date: 2019-08-01
- Location: SOUTH SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0001673772
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $556.83M
- Round Lot: 100
- Outstanding Shares: 16.54M
- Asset Type: CS
RECENT FILINGS FOR RAPT
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-20 | 8-K | View |
| 2025-08-14 | SCHEDULE 13G | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-07-08 | 8-K | View |
| 2025-06-30 | 4 | View |
| 2025-06-30 | 3 | View |
| 2025-06-24 | 4 | View |
| 2025-06-24 | 3 | View |
| 2025-06-24 | 4 | View |
| 2025-06-24 | 4 | View |
| 2025-06-24 | 4 | View |
| 2025-06-24 | 4 | View |
| 2025-06-23 | 8-K | View |
| 2025-06-20 | S-8 | View |
| 2025-06-17 | 8-K | View |
| 2025-06-09 | 8-K | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
Latest News on RAPT